Form 144 CAMTEK LTD Filed by: Aviram Lior
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 8-K Milestone Pharmaceutical For: Aug 12
false
0001408443
A8
00-0000000
QC
0001408443
2026-08-12
2026-08-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)... (continue reading...)
Form 8-K Applied Aerospace & Defe For: Aug 12
0002118195false00021181952026-08-122026-08-12UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549___________________________________FORM 8-K___________________________________CURRENT REPORTPursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934Date of Report (date of earliest event reported): August 12, 2026___________________________________Applied Aerospace & Defense, Inc.(Exact name of registrant as specified in its charter)... (continue reading...)
Form D/A Redwheel EAFE Intrinsic
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 10-D First National Master For: Jul 31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-D
ASSET-BACKED ISSUER DISTRIBUTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the monthly distribution period from July 1, 2026 to July 31, 2026.
Commission File Number of issuing entity: 333-265964
Central Index Key Number of issuing entity: 0001396730
First National Master Note Trust
More SEC Filings
View Older Stories-
Form 4 Matador Resources Co For: Aug 10 Filed by: Foran Joseph Wm
-
Form 13F-HR PGGM Investments For: Jun 30
-
Form 6-K RADCOM LTD For: Aug 12
-
Form 8-A12B AMCON DISTRIBUTING CO
-
Form 8-K SUTRO BIOPHARMA, INC. For: Aug 12
-
Form SCHEDULE 13G/A EXELIXIS, INC. Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 8-K ZION OIL & GAS INC For: Aug 12
-
Form 424B5 ZION OIL & GAS INC
-
Form 10-Q HG Holdings, Inc. For: Jun 30
-
Form 10-Q CYPHERPUNK TECHNOLOGIES For: Jun 30
-
Form 8-K AMCON DISTRIBUTING CO For: Aug 06
-
Form 8-K TScan Therapeutics, Inc. For: Aug 12
-
Form SCHEDULE 13G/A CARMAX INC Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 13F-HR STOREBRAND ASSET MANAGEM For: Jun 30
-
Form N-PX PFA Pension, Forsikrings For: Jun 30
-
Form 8-K CYPHERPUNK TECHNOLOGIES For: Aug 12
-
Form 4 Paycom Software, Inc. For: Aug 10 Filed by: Boelte Craig E.
-
Form 10-Q Protalix BioTherapeutics For: Jun 30
-
Form SCHEDULE 13G/A agilon health, inc. Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 13F-HR NORGES BANK For: Jun 30
-
Form 8-K Cycurion, Inc. For: Aug 07
-
Form 10-Q Octave Intelligence plc For: Jun 30
-
Form 6-K KAMADA LTD For: Jun 30
-
Form 8-K Fervo Energy Co For: Aug 12
-
Form 10-Q Lexeo Therapeutics, Inc. For: Jun 30
-
Form 6-K AVINO SILVER & GOLD MINE For: Aug 12
-
Form 6-K HYDRO ONE INC For: Jun 30
-
Form 6-K Hydro One Ltd For: Jun 30
-
Form 13F-HR First Beijing Investment For: Jun 30
-
Form 6-K SIMILARWEB LTD. For: Jun 30
-
Form 8-K Lexeo Therapeutics, Inc. For: Aug 12
-
Form 8-K Humacyte, Inc. For: Aug 12
-
Form 6-K Hydro One Ltd For: Jun 30
-
Form 6-K Can-Fite BioPharma Ltd. For: Aug 12
-
Form 6-K Costamare Inc. For: Aug 12
-
Form 8-K Acumen Pharmaceuticals, For: Aug 12
-
Form 8-K Octave Intelligence plc For: Aug 12
-
Form 8-K TRIMBLE INC. For: Aug 12
-
Form SCHEDULE 13G/A EDISON INTERNATIONAL Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 6-K AVINO SILVER & GOLD MINE For: Jun 30
-
Form 10-Q Milestone Pharmaceutical For: Jun 30
-
Form 8-K/A Bausch & Lomb Corp For: Aug 05
-
Form 4 Chiron Real Estate Inc. For: Aug 10 Filed by: Decker Mark Okey Jr
-
Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30
-
Form 10-Q WhiteFiber, Inc. For: Jun 30
-
Form 8-K Sound Point Meridian For: Aug 03
-
Form 8-K Performance Food Group For: Aug 12
-
Form 4 Chiron Real Estate Inc. For: Aug 10 Filed by: Fitzgerald Charles
-
Form 8-K Protalix BioTherapeutics For: Aug 12
-
Form 6-K Jumia Technologies AG For: Aug 12
